Peroxisomal disorder

Peroxisomal disorder

Basic structure of a peroxisome
Classification and external resources
Specialty endocrinology
ICD-10 E80.3
ICD-9-CM 277.86
eMedicine neuro/309
MeSH D018901

Peroxisomal disorders represent a class of medical conditions caused by defects in peroxisome functions.[1] This may be due to defects in single enzymes[2] important for peroxisome function or in peroxins, proteins encoded by PEX genes that are critical for normal peroxisome assembly and biogenesis.[3]

Peroxisome biogenesis disorders

Peroxisome biogenesis disorders (PBDs) include the Zellweger syndrome spectrum (PBD-ZSD) and rhizomelic chondrodysplasia punctata type 1 (RCDP1).[4][5] PBD-ZSD represents a continuum of disorders including infantile Refsum disease, neonatal adrenoleukodystrophy, and Zellweger syndrome. Collectively, PBDs are autosomal recessive developmental brain disorders that also result in skeletal and craniofacial dysmorphism, liver dysfunction, progressive sensorineural hearing loss, and retinopathy.[4][5]

PBD-ZSD is most commonly caused by mutations in the PEX1, PEX6, PEX10, PEX12, and PEX26 genes.[6][7] This results in the over-accumulation of very long chain fatty acids and branched chain fatty acids, such as phytanic acid. In addition, PBD-ZSD patients show deficient levels of plasmalogens, ether-phospholipids necessary for normal brain and lung function.

RCDP1 is caused by mutations in the PEX7 gene, which encodes the PTS2 receptor.[8] RCDP1 patients can develop large tissue stores of branched chain fatty acids, such as phytanic acid, and show reduced levels of plasmalogens.

Name OMIM Gene ICD-10
Zellweger syndrome 214100 PEX1, PEX2, PEX3, PEX5, PEX6, PEX12, PEX14, PEX26 Q87.82
Infantile Refsum disease 266510 PEX1, PEX2, PEX26 E80.3
Neonatal adrenoleukodystrophy 202370 PEX5, PEX1, PEX10, PEX13, PEX26 E71.331
RCDP Type 1 215100 PEX7 Q77.3

Enzyme and transporter defects

Peroxisomal disorders also include:

Name OMIM Gene ICD-10 NA[9]
Pipecolic acidemia 600964 PHYH E80.301
Acatalasia 115500 CAT E80.310
Hyperoxaluria type 1 259900 AGXT E80.311
Acyl-CoA oxidase deficiency 264470 ACOX1 E80.313
D-bifunctional protein deficiency 261515 HSD17B4 E80.314
Dihydroxyacetonephosphate acyltransferase deficiency 222765 GNPAT E80.315
X-linked adrenoleukodystrophy 300100 ABCD1 E71.33
α-Methylacyl-CoA racemase deficiency 604489 AMACR
RCDP Type 2 222765 DHAPAT Q77.3
RCDP Type 3 600121 AGPS Q77.3
Adult Refsum disease-1 266500 PHYH G60.1
Mulibrey nanism 253250 TRIM37

Additional resources for patients and families

The mission of the ELA is to help and support families affected by leukodystrophy, to stimulate the development of research thanks to the ELA Foundation created in 2005, to raise public awareness, to develop its work at international level. ELA is thus a bridge between all forms of leukodystrophy and a family solidarity network.

The mission of The Global Foundation for Peroxisomal Disorders is to help children and families faced with a diagnosis of a Peroxisomal Biogenesis Disorder (in the Zellweger Spectrum of Disorders) and to assist family members and professionals through educational programs, research, and support services.

Rhizokids is dedicated to providing support for families affected by RCDP, promoting awareness of RCDP, and raising funds for RCDP research so that one day we will have a cure!

The United Leukodystrophy Foundation is dedicated to helping children and adults who have leukodystrophy and assisting the family members, professionals and support services that serve them. The ULF is committed to the identification, treatment and cure of all leukodystrophies through programs of education, advocacy, research and service.

Our mission is to promote, advance, and improve awareness of Zellweger syndrome and other peroxisomal disorders, to assist, support, and aid, financially or otherwise, individuals and families affected by Zellweger syndrome.

References

  1. ↑ Wanders, R. J. A.; Waterham, H. R. (2006). "Biochemistry of Mammalian Peroxisomes Revisited". Annual Review of Biochemistry 75: 295–332. doi:10.1146/annurev.biochem.74.082803.133329. PMID 16756494.
  2. ↑ Wanders, R.; Waterham, H. (2006). "Peroxisomal disorders: the single peroxisomal enzyme deficiencies". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1763: 1707–20. doi:10.1016/j.bbamcr.2006.08.010. PMID 17055078.
  3. ↑ Weller, S.; Gould, S. J.; Valle, D. (2003). "Peroxisome Biogenesis Disorders". Annual Review of Genomics and Human Genetics 4: 165–211. doi:10.1146/annurev.genom.4.070802.110424. PMID 14527301.
  4. 1 2 Steinberg, S.; Dodt, G.; Raymond, G.; Braverman, N.; Moser, A.; Moser, H. (2006). "Peroxisome biogenesis disorders". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1763 (12): 1733–48. doi:10.1016/j.bbamcr.2006.09.010. PMID 17055079.
  5. 1 2 Steinberg, S.; Raymond, G.; Braverman, N.; Moser, A.; Pagon, H.; Adam, R.; Bird, T.; Dolan, C.; Fong, K.; Stephens, K. (1993). "Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum". PMID 20301621.
  6. ↑ Steinberg, S.; Chen, L.; Wei, L.; Moser, A.; Moser, H.; Cutting, G.; Braverman, N. (2004). "The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum". Molecular Genetics and Metabolism 83 (3): 252–263. doi:10.1016/j.ymgme.2004.08.008. PMID 15542397.
  7. ↑ Yik, W. Y.; Steinberg, S. J.; Moser, A. B.; Moser, H. W.; Hacia, J. G. (2009). "Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders". Human Mutation 30 (3): E467–E480. doi:10.1002/humu.20932. PMC 2649967. PMID 19105186.
  8. ↑ Braverman, N.; Steel, G.; Obie, C.; Moser, A.; Moser, H.; Gould, S. J.; Valle, D. (1997). "Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata". Nature Genetics 15 (4): 369–376. doi:10.1038/ng0497-369. PMID 9090381.
  9. ↑ World Health Organization (7 December 1997). Application of the international classification of diseases to neurology: ICD-NA. World Health Organization. pp. 119–. ISBN 978-92-4-154502-0. Retrieved 23 November 2010.

External links

This article is issued from Wikipedia - version of the Thursday, January 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.